®

IMMUNOTHERAPY UPDATES 2020 17TH JULY 2020 / WEBINAR

ORGANIZED BY SUPPORTED BY

CME Accredited

CLICK HERE TO REGISTER E-Brochure Speaker Bio

Shaheenah Dawood UAE

Shaheenah Dawood is a Consultant medical oncologist and associate professor in clinical oncology in the United Arab Emirates. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. ® Axel Grothey USA

Axel Grothey, MD, is a medical oncologist and Director of Gastrointestinal Cancer Research at West Cancer Center and Research Institute, in Germantown, Tennessee.Dr Grothey received his medical degree at Ruhr-Universität Bochum, Germany, and completed residencies at West German Tumor Center and the Institute of Pathology at the University of Essen and a residency and fellowship at the University of Bochum.

Deborah Mukherji Lebanon

Dr Deborah Mukherji is an Associate Professor of Clinical Medicine (Oncology) who joined the faculty of the AUBMC in June 2012. Dr Mukherji completed her advanced specialty training in Medical Oncology at Guys and St Thomas’s NHS Foundation Trust, London UK and was awarded a Post-Graduate Diploma in Oncology from the Institute of Cancer Research, University of London in 2011.

Faraz Khan UAE

Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. 2 Speaker Bio

Fathi Azribi UAE

Dr Fathi Al Azribi is Consultant Medical Oncologist & Division Chief at Tawam Hospital Medical Oncology Fellowship Program Director

Hamdy Abdul Azim Egypt

Dr Azim is a Professor of Clinical Oncology and immediate past chairman of the Department of Clinical Oncology, Faculty of Medicine, Cairo University. He is the president of the Cairo Oncology Center, one of the largest private Cancer centers in the Middle East region. ®

Ikram Burney Oman

Dr Ikram Burney in consultant in Medical Oncology at SQUH. He graduated from Pakistan and received his training in Medical oncology at the Aga Khan University, Karachi, Hammersmith Hospital London, and Southampton University Hospitals in the UK. He worked as a consultant Oncologist at the Aga Khan University Hospital in Karachi, Pakistan. He has been working at SQUH, Oman since 2003 as a Senior consultant in Medical Oncology.

Muath Nassar Kuwait

Dr. Muath Nassar is Consultant medical oncologist, head of thoracic and sarcoma unit at Kuwait Cancer Control Center, Fellowship from Western University London Ontario, Canada . 3 Speaker Bio

Mohsen Mokhtar Egypt

Chief Medical Director Dr. Mohsen Mokhtar is a professor of clinical oncology in Al-Kasr Al-Aini Medical School. Dr. Mohsen assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses.

Nouri Benini UAE ® Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.

Sanjay Popat UK

Professor Popat has both a private and an NHS practice at The Royal Marsden. Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.

Tobias Arkenau UK

Dr Hendrik-Tobias Arkenau is the founding Medical Director of Sarah Cannon Research Institute UK, and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the Hospital Corporation of America International Cancer Service Line.Dr Arkenau has vast experience in Early Oncology Clinical Drug Development with a special interest in gastrointestinal cancer and melanoma. 4 Speaker Bio

Abdulrahman Zar Qatar

Dr. Abdul Rahman Zar is currently a Consultant Medical Oncologist and Assistant Fellowship Director at the National Cancer Care Center and Research (NCCCR) of Hamad Medical Corporation. He is the Lead of Head and Neck MDT and CORE member of GI MDT. Dr Abdul Rahman Zar has received his medical degree from the Khyber Medical University, Peshawar, Pakistan.

Christian Rolfo USA

Christian Rolfo, MD, PhD, MBA is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). He specializes in thoracic oncology, drug development and translational oncology.

Peter Schmid UK

Peter Schmid is Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute. He is the Clinical Director of the St. Bartholomew Breast Cancer Centre and Honorary Consultant Medical Oncologist at Barts Hospital. He also leads the Cancer Immune Therapy group at Barts Hospital.

Pier Luigi Zinzani Italy

Pier Luigi Zinzani is Professor in Department of Experimental, Diagnostic and Specialty Medicine – DIMES at University of Bologna. He has been Awarded a “Post-Doctoral Fellowship in Medical Physics” released by the “Roger Williams Cancer Ospitale” of Providence (USA) in 1989 5 Program

17:00 - 17:10 Welcome Key Note Shaheenah Dawood, UAE

17:12 – 19:25 Session 1 Chair: Faraz Khan, UAE

17:12 – 17:32 In the era of IO dual immunotherapy in the management of front line NSCLC Supported by BMS Fathi Al Azribi, UAE

17:35 – 17:55 Immunotherapy updates in breast cancer Supported by Roche Peter Schmid, UK

17:57 – 18:12 Immunotherapy cases in breast cancer Hamdy A. Azim, Egypt

18:14 – 18:29 Immunotherapy updates in GI malignancies Axel Grothey, USA

18:31 – 18:46 Immunotherapy updates in GU malignancies Deborah Mukherji, Lebanon ®

18:48 – 19:03 Immunotherapy updates in lung cancer Sanjay Popat, UK

19:05 – 19:25 Case Studies in first line management of NSCLC Christan Rolfo, USA 19:25 – 19:40 Break 6 Program

19:40 – 20:34 Session 2 Chair: Nouri Bennini, UAE

19:40 – 20:00 Updates on role of checkpoint inhibitors in classical Hodgkin Lymphoma Pier Luigi Zinzani, Italy

20:02 – 20:17 Defining the role of Dual immunotherapy approaches in solid malignancies Tobias Arkenau, UK

20:19 – 20:34 Challenging case discussion sessions highlighting management of toxicity related to immunotherapy Mohsen Mokhtar, Egypt

20:36 – 21:06 Panel discussion Moderator: Shaheenah Dawood, UAE Panellist: Hamdy A. Azim, Egypt | Tobias Arkenau, UK | Mohsen Mokhtar, Egypt | Sanjay Popat, UK Deborah Mukherji, Lebanon | Axel Grothey, USA | Fathi Al Azribi, UAE Abdulrahman Zar, Qatar | Ikram Burney, Oman | Muath Nassar, Kuwait | Peter Schmid, UK

21:08 – 21:15 Closing Remark Shaheenah Dawood 7 Next Virtual Events

® VISIT OUR WEBSITE FOR REGISTRATION 24 JULY 2020 & MORE DETAILS: CANCERCONGRESS.AE Timing: 17:00 - 21: 30 Hrs BREAST CANCER UPDATES 2020

VISIT OUR WEBSITE FOR REGISTRATION 21 AUGUST 2020 & MORE DETAILS: IBRCAF.COM

VISIT OUR WEBSITE FOR REGISTRATION 22 - 23 AUGUST 2020 & MORE DETAILS: APGCS.COM

ORGANIZED BY

INDEX Holding Headquarters, Road # D-62, Opposite Nad Al Hamar P.O. Box: 13636, Dubai, UAE | Tel: +971 4 520 8888, Fax: +971 4 338 4193 Email: [email protected], Website: cancercongress.ae